Global Oxygen Therapy Equipments Market Size By Type (Stationary Devices, Portable Devices), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 to 2032

The Global Oxygen Therapy Equipment Market was valued at USD 4.1 billion in 2023 and is projected to surpass USD 7.3 billion by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. This growth is driven by the increasing prevalence of respiratory disorders, advancements in portable oxygen devices, and the rising aging population globally. Oxygen therapy equipment plays a critical role in managing conditions like chronic obstructive pulmonary disease (COPD), asthma, and hypoxemia, thereby enhancing patients' quality of life and survival outcomes.

Drivers:

1. Rising Incidence of Respiratory Diseases:

The global burden of respiratory diseases such as COPD and asthma continues to rise, largely due to pollution, smoking, and occupational hazards. This trend has significantly increased the demand for long-term oxygen therapy, particularly in aging populations.

2. Technological Advancements in Portable Devices:

Innovations in oxygen concentrators, particularly in portable and lightweight designs, are boosting patient compliance and enabling greater mobility. These developments are expanding the scope of homecare oxygen therapy.

3. Growing Preference for Home Healthcare:

A shift towards home-based care due to cost-effectiveness and patient comfort is driving the adoption of oxygen therapy equipment outside clinical settings, especially in developed regions.

Restraints:

1. High Cost of Advanced Devices:

The cost of high-end oxygen therapy systems, especially portable concentrators and ventilators, remains a barrier, particularly in low- and middle-income countries, limiting broader accessibility.

2. Reimbursement Limitations:

Reimbursement policies for oxygen therapy equipment vary widely across regions and often lag behind evolving technologies, impeding market penetration in certain areas.

Opportunity:

1. Untapped Emerging Markets:

Countries in Asia-Pacific and Latin America offer substantial growth potential due to increasing healthcare awareness, growing middle-class populations, and expanding health infrastructure.

2. Integration with Smart Monitoring Technologies:

The integration of oxygen delivery systems with digital health platforms and wearable sensors is expected to enhance patient monitoring, adherence, and outcomes, opening new revenue streams.

Market by System Type Insights:

Based on system type, the Oxygen Concentrators segment dominated the market in 2023. These devices are favored for their cost-efficiency, ease of use, and growing application in home healthcare. Portable oxygen concentrators are especially witnessing high adoption due to their convenience and mobility. The Liquid Oxygen Systems segment is also expected to grow steadily, driven by hospital and ambulatory applications.

Market by End-Use Insights:

In terms of end-use, the Home Healthcare segment emerged as the largest contributor in 2023, accounting for over 45% of the global revenue. Increasing patient preference for home-based treatments, combined with the advancement in compact and user-friendly devices, supports this trend. The Hospitals & Clinics segment continues to play a crucial role, particularly in critical care and emergency settings.

Market by Regional Insights:

North America led the global market in 2023, owing to the high prevalence of COPD and favorable reimbursement policies. However, Asia-Pacific is anticipated to register the fastest growth during the forecast period due to increasing healthcare investments, an aging population, and rising pollution levels.

Competitive Scenario:

Key players in the global oxygen therapy equipment market include Philips Healthcare, Invacare Corporation, ResMed Inc., Drive DeVilbiss Healthcare, Teijin Limited, Inogen Inc., CAIRE Inc., Fisher & Paykel Healthcare, O2 Concepts LLC, and Nidek Medical Products Inc. These companies focus on R&D, product innovation, and strategic partnerships to enhance their global footprint.

Scope of Work – Global Oxygen Therapy Equipment Market

Key Market Developments:

In 2023, Philips Healthcare launched a new generation of connected portable oxygen concentrators with Bluetooth-enabled real-time monitoring.

In 2024, Inogen Inc. entered a strategic partnership with a major telehealth provider to integrate oxygen therapy with remote monitoring systems.

In 2025, ResMed expanded its homecare respiratory solutions portfolio by acquiring a digital respiratory health startup.

FAQs:

1) What is the current market size of the Global Oxygen Therapy Equipment Market?

The market was valued at USD 4.1 billion in 2023.

2) What is the major growth driver of the Global Oxygen Therapy Equipment Market?

The rising prevalence of respiratory disorders and increasing demand for portable and home-use oxygen therapy devices.

3) Which is the largest region during the forecast period in the Global Oxygen Therapy Equipment Market?

North America is currently the largest market, while Asia-Pacific is expected to grow the fastest.

4) Which segment accounted for the largest market share in the Global Oxygen Therapy Equipment Market?

The Oxygen Concentrators segment led by system type, and Home Healthcare led by end-use in 2023.

5) Who are the key market players in the Global Oxygen Therapy Equipment Market?

Key players include Philips Healthcare, ResMed Inc., Inogen Inc., CAIRE Inc., and Drive DeVilbiss Healthcare.